



Background: Glomerular filtration rate (GFR) is the best measure of renal function. However, the ideal exogenous 
markers are not routinely used to estimate GFR in clinical settings. Outside Africa, GFR estimates for neonates have 
been calculated from formulae using creatinine as well as cystatin C. There is a paucity of data on estimated GFR in 
neonates in Africa. This study was conducted to estimate GFR in healthy term African neonates using cystatin 
C-based equations. 
Methods: One hundred and thirteen apparently healthy term babies with normal Apgar scores were recruited at 
birth. Cystatin C was measured in cord blood at birth and in venous samples from neonates on the third day of life. 
GFR was estimated using the Filler and Lepage as well as the Zappitelli et al. cystatin C-based equations. These 
estimates were compared with a reference GFR estimate of 41 ± 15 mL/min/1.73 m2. 
Results: The median (interquartile range) estimated GFR values based on cord blood and day 3 venous samples 
using the Filler and Lepage equation were 44.67 (36.35–72.44) and 51.29 (38.90–72.44) mL/min/1.73 m2, respectively. 
When the Zappitelli equation was applied, the estimates were 38.18 (31.84–61.34) and 43.82 (33.75–61.34) mL/
min/1.73 m2, respectively. The GFR estimates derived from both equations did not differ in respect of the gestational 
age, sex and postnatal ages of the babies.
Conclusions: GFR estimates using the Zappitelli equation had values that were closely related to reference GFR 
measures for neonates whereas the GFR estimates using the Filler and Lepage equation had higher values.  
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INtrODUctION
Glomerular filtration rate (GFR) is defined as the volume 
of plasma that is completely cleared of a particular 
substance by the kidneys in a unit of time [1]. GFR is 
widely accepted as the best measure of renal function 
[2-4]. In order to detect abnormal renal function, it is 
important to establish reference values for GFR using 
reliable methods of evaluation.
The most precise method for measuring GFR is to use 
exogenous markers like inulin. Measurement of inulin 
clearance involves the intravenous injection of a priming 
dose followed by constant infusion and meticulous urine 
sampling. Other exogenous markers such as iohexol, 
sodium iothalamate, technetium-diethylenetriamine-
pentaacetic acid (Tc-DTPA), and chromiume-thylene-
diaminetetraacetic acid (Cr- EDTA) have also been used. 
Although the use of these exogenous markers is the gold 
standard, the need for frequent blood sampling, careful 
urine collection and constant infusions limits their use in 
the clinical setting. Because of these limitations, re-
searchers have sought simpler methods of assessing GFR.
Serum creatinine has been used to estimate GFR for 
decades. Plasma or serum creatinine as a marker of renal 
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function is not ideal as it is dependent on muscle mass, 
gender, age and tubular maturity [5,6], it crosses the 
placenta and thus reflects maternal values in the first days 
of life [6,7] and it is insensitive to small changes in GFR [6]. 
Finally, the Jaffe method, which is the most commonly used 
method for measuring creatinine, is prone to interference 
in conditions such as hyperbilirubinaemia, haemolysis and 
ketosis [1,6]. This leads to falsely high serum creatinine 
measurements and underestimation of GFR.
Serum cystatin C has been proposed as a more reliable 
marker in children and adults and offers significant 
advantages over serum creatinine. Cystatin C may also be 
used to replace creatinine when assessing renal function in 
neonates. Cystatin C is a cysteine proteinase inhibitor, 
which is involved in the intracellular catabolism of pro- 
teins [6]. It is expressed in all nucleated cells and pro- 
duced at a constant rate [8]. Many studies have validated 
the use of cystatin C as a marker of renal function in 
paediatric populations [1,9,10]. Cystatin C appears to be a 
more specific and sensitive marker of GFR in neonates and 
older children compared to creatinine [1,10,11-14].
There are few studies that have evaluated renal function in 
neonates using ideal exogenous markers [15]. In studies 
conducted outside of Africa, GFR estimates have been 
reported using the clearance of creatinine [16,17] and 
cystatin C [15,18]. To the best of our knowledge, no GFR 
estimates have been documented in African neonates. The 
objectives of the present study were to estimate GFR in 
apparently healthy neonates in Nigeria at birth and on the 
third day of life, using cystatin C-based equations, and to 
compare the estimated GFR with previously published 
reference values [15,16]. This study therefore provides 
useful data on the normal values for renal function in 
healthy African neonates. The results reported here focus 
on GFR and represent part of a larger study; details of the 
methods and results of cystatin C levels have been 
published previously [22].
MEtHODs
This was a prospective study of apparently healthy full-term 
neonates delivered at the Obstetrics and Gynaecology unit 
of a Mother and Child Health Facility in Lagos State from 
October to December 2014. The hospital is the Obstetrics 
and Gynaecology annex of the Lagos State University 
Teaching Hospital (LASUTH), a tertiary institution in South 
West Nigeria. 
We recruited 113 full-term, apparently healthy babies after 
normal pregnancy, labour and delivery. These were babies 
with a 5-minute Apgar score of more than 7, and who had 
a birth weight that was appropriate for gestational age. 
Babies who experienced conditions likely to affect renal 
function were excluded. These included babies of mothers 
with hypertension, babies with gross congenital anomalies 
and those who developed fever or evidence of systemic 
illness by the third day of life.
Blood samples were obtained from the umbilical cord at 
birth and venous samples on the third day of life. Serum 
cystatin C was measured on the samples using Human 
Cystatin C ELISA kits (BioVendor-Laboratorni a.s., Czech 
Republic) [19]. The calibration range of the assay was 200–
10,000 ng/mL, with a limit of detection of 0.25 ng/mL. Its 
intra-assay coefficient of variation was 2.5% and the inter-
assay coefficient of variation was 6.9%. 
Estimated GFR (eGFR), expressed in mL/min/1.73 m2, was 
calculated using two prediction equations, with cystatin C 
concentration in mg/L:
Filler and Lepage equation [20]: Log(eGFR) = 1.962 + 
[1.123 x log (1/cystatin C)]
Zappitelli et al. equation [21]: eGFR = 75.94 x cystatin 
C –1.17.
Data analysis was preformed using Microsoft Excel 2013 
and the Statistical Package for Social Sciences (SPSS) 
version 20.0. Mean and standard deviation were calculated 
for variables that were normally distributed; median and 
interquartile range were used for variables that were not 
normally distributed. Comparisons between groups were 
made using Student’s t-test, and the Wilcoxon signed-rank, 
Mann–Whitney U and Kruskal–Wallis tests were used for 
non-parametric data. P-values of less than 0.05 were 
considered statistically significant.
Approval for the study was granted by the Health Research 
and Ethics Committee of LASUTH. Informed consent was 
obtained from the parents of the neonates. The parents of 
babies with congenital anomalies or evidence of renal 
impairment were counselled and referred for appropriate 
follow-up. 
rEsULts
A total of 144 babies were recruited, but 24 did not 
return for evaluation on the third day of life, or were ill on 
that day, and so were excluded from the study. Another 
seven had haemolysed samples and were also excluded. 
The remaining neonates were 45 males and 68 females 
(ratio 1:1.5). Their baseline characteristics are summarised 
in Table 1. Most of the babies were delivered at 37–38 
weeks. The birth weight ranged from 2.5–4.5 kg, with a 
mean weight of 3.4 ± 0.5 kg. 
The mean cystatin C values at birth and on day 3, as 
reported previously, were 1.67 ± 0.52 mg/L and 1.62 ± 
0.52 mg/L, respectively, with medians of 1.8 and 1.6 mg/L 
[22]. There were no differences based on the time of 
sampling or the sex of the neonates (Figure 1).
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Table 2 shows the eGFR values calculated using the Filler 
and Lepage equation [20]. The median eGFR was 44.67 
and 51.29 mL/min/1.73 m2 at birth and on day 3, respec-
tively. There was no difference between males and females 
or between the samples taken at birth and on day 3.
The eGFR values using the Filler and Lepage equation were 
grouped from the lowest to the highest (Table 3). There 
were no values less than 25 mL/min/1.73 m2. The distri-
bution of eGFR values was similar for both birth and day 3 
samples (p = 0.403).
There was no significant difference in the eGFR values 
across the different gestational ages for both cord blood 
and day 3 venous samples (Table 4).
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*SVD, spontaneous vaginal delivery.
table 2.  Estimated GFR* (median and interquartile range) 
using the Filler and Lepage equation [20].




















*GFR in mL/min/1.73 m2.
table 4.  Effect of gestational age on eGFR values using the 
Filler and Lepage equation at birth and on day 3.
Age (weeks) n Birth Day 3 p
37 18      55.07     58.94 0.796
38     39 47.35 50.50 0.766
39 16 62.78 58.42 0.887
40 26 47.35 59.60 0.192
41 14 44.56 46.6 0.638
p 0.425 0.454
table 3.  Distribution of eGFR values using the Filler and 
Lepage [20] equation at birth and on day 3.
GFR 
(mL/min/1.73 m2)       
Birth 
[n=113 (%)]      
Day 3 
[n=113 (%)]          
≤25.0                                               0 (0.0)                       0 (0.0)                      
25.1–40.0                                     41(36.3) 30 (26.5)
40.1–55.0                                     25 (22.1) 33 (29.2)
55.1–70.0                                      18 (15.9) 20 (17.7)
≥70.1                                           29 (25.7) 30 (26.5)
Figure 1.  Serum cystatin C in samples from neonates at 





















Birth         Day 3
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The eGFR values calculated using the Zappitelli equa- 
tion [21] are shown in Table 5. Once again, there was no 
difference between males and females or between the 
samples taken at birth and on day 3.
The distribution of eGFR values using the Zappitelli 
equation (Table 6) was similar for samples taken at birth 
and on day 3. The largest number of samples was in the 
group with eGFR 25.1–40 mL/min/1.73 m2.
As noted with eGFR values calculated using the Filler and 
Lepage equation, there was no difference by gestational 
age at birth or by day 3.
The eGFR values obtained using the Filler and Lepage 
equation were significantly higher than those using the 
Zappitelli equation (Table 7, p < 0.001).
Figure 2 illustrates the distribution of eGFR values derived 
from both equations. The plot depicts medians and 
interquartile ranges, and outliers; the reference GFR is 
represented by the horizontal line across the graph. The 
spread of the estimates from the Filler and Lepage equation 
was greater and the estimates from the Zappitelli equation 
were more closely related to the reference value for both 
birth (cord blood) and day 3 samples.
DIscUssION
We found that eGFR values calculated using the Filler 
and Lepage equation were higher than the reference 
values obtained from creatinine clearance in previous 
studies [17,23]. The eGFR values were also higher than 
those reported by Treiber et al. using a cystatin C-based 
equation formulated for neonates [15]. One reason for 
these differences may be that the Filler and Lepage equa-
tion overestimates GFR in children [13,15,24,25]. Since 
the development of the cystatin C equation by Filler and 
Lepage, some researchers have noted that the equa- 
tion overestimates GFR especially in the low GFR 
ranges [15,26], whereas others reported that the equa- 
tion correctly estimates GFR in children [21].
GFR was also estimated using the Zappitelli equation [21] 
because it has been proven to be more reliable when 
applied to older children and neonates [15,18,26,27]. 
eGFR derived from the Zappitelli equation in our study 
was comparable with the measured reference range from 
creatinine clearance [17,23] and the eGFR from the 
recently published cystatin C equation derived for neo-
nates [15]. Other researchers have also estimated GFR in 
neonates using the Zappitelli equation in neonates and 
reported that the eGFR from that equation was com-
parable with reference values measured by creatinine 
clearance [15,18,27].
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table 5.  Estimated GFR values using the Zappitelli equation.
eGFR median and interquartile range  
(25th and 75th percentiles)
Gender Birth Day 3 p
Male 38.18 (30.18–64.63) 45.83 (33.75–61.34) 0.39
Female 38.18 (33.75–59.98) 42.32 (35.84–56.63) 0.98
Total 38.18 (31.84–61.34) 43.82 (33.75–61.34) 0.60
p 0.93 0.34
table 6.  Distribution of eGFR values using the Zappitelli 





Day 3  
[n (%)] p
≤25.0                                              5 (4.4) 4 (3.5) 0.807
25.1–40.0                    54 (47.8) 47 (41.6)
40.1–55.0                    19(16.8) 24 (21.2)
55.1–70.0                        18 (16.0) 22 (19.5)
≥70.1                                              17 (15.0) 16 (14.2)
table 7.  Comparison of eGFR values using the Filler and 
Lepage, and Zappitelli equations.
Filler and Lepage Zappitelli p
≤25.0    44.67 (36.35–72.44) 38.18 (31.84–61.34) 0.002
≥70.1    51.29 (38.90–72.44) 43.82 (33.75–61.34) 0.003
Figure 2.  Estimated GFR (eGFR in mL/min/1.73 m2) using 
cystatin C-based equations in samples from neonates at birth 
and on day 3.
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In the present study, eGFR values calculated using the Filler 
and Lepage equation were significantly higher than those 
from the Zappitelli equation. This finding has also been 
documented in the study by Treiber et al. [15]. Given that 
the GFR estimates from the Zappitelli equation were more 
closely related to the reference GFR from the literature, 
the estimates from that equation may be used as reference 
values when investigating neonates at risk of renal injury in 
the first few days of life.   
We observed that eGFR was independent of the gesta-
tional age, postnatal age and sex of the babies. This was not 
surprising, given that, in utero, GFR plateaus after the 36th 
week of gestation until birth. Thereafter, GFR correlates 
with postnatal age [6,23]. Previous reports have shown 
that there is no significant difference in the values in the 
first three days of life [15,28]. The implication is that 
separate reference values need not be generated for sex, 
gestational age of term babies and postnatal age in the first 
three days of life.
Some limitations were encountered: first, the inability to 
determine GFR using a gold standard method, which would 
have been compared with the estimates calculated from 
the cystatin C equations. Second, the study included only 
term babies sampled at birth and on the third day of life. 
Third, the study would have added more value if preterm 
babies had been included and if all babies were also sampled 
at one month of age. The cost of the assays restricted the 
scope of the study. 
cONcLUsIONs
GFR calculated using the Filler and Lepage equation yielded 
higher values than the estimates derived from the Zappitelli 
equation, which were comparable with GFR estimated 
using creatinine clearance in neonates.
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